|
|
Invalidenstrasse 130
Berlin, 10115 Germany
phone:(49) 30 9 78 93 0
fax:(49) 30 9 78 93 105
|
|
| Symbol |
JI4 |
| Exchange |
FRA |
| Founded |
0 |
| Employees |
|
|
|
| www.jerini.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Development of peptide-derived drugs. |
|
| Management |
| Theresa Heggie, Chief Executive Officer; Dr. Whaijen Soo,
Chief Scientific Officer; Christian von Volkmann, Chief Financial Officer; Dr. Rainer Kramer, Vice President Business Development; Dr. Laurence Jobron, Vice President Project Management & Preclinical Development |
| |
|
|
|
|
|
|
|
| Keywords |
| peptide, drugs, p2d, peptidomimetic, drug, molecules, targets, chronic, cancer, rheumatoid, arthritis, diagetic, nephropathy, psoriasis, blood, vessels, oncology |
|
|
|
| Description |
|
Jerini specializes in the discovery and development of peptide-derived drugs. Jerini provides systematic discovery and development of peptidomimetic and small molecule drugs derived from peptides. |
|
| Technology / Differentiation |
| The company developed its Peptides-to-Drugs (P2D) technology platform to convert peptide leads into peptidomimetic drugs and drug-like small molecules. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
